NAN.AU Nanosonics Ltd

Healthcare Health Care Equipment & Supplies Australian Securities Exchange
3.03 AUD
Close of Nov 1, 2026
2.64 4.56
Market cap
AUD 906M
P/E
50.5x
P/B
4.17x
ROE
8.2%
Dividend yield
-
Fundamental score
2.0/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is NAN.AU undervalued?

Graham number

The Graham number of Nanosonics Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nanosonics Ltd fundamental analysis

9 of 22 checks passed

ROE 0/2

Low return on equity (8.2%), below 10%.

ROA 1/1

Return on assets (5.7%) is above the industry median (-35.3%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-13.7%) is not above the 5-year average (15.5% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-13.7%) is below the industry median (24.9%).

Revenue Growth 1/2

Revenue grew 6.7% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (10.6%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 8.9x against interest expense, well covered.

PE vs Market 0/1

PE (50.5x) is above the market median (15.0x).

PE vs Industry 0/1

PE (50.5x) is above the industry median (36.4x).

PBV 0/1

Price to book (4.2x) is above the industry median (4.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 210.5, limit 22.5).

PEG 0/1

PEG on 5-year earnings growth is 3.26, above 1.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Nanosonics Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nanosonics Ltd

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infec…

Full company profile